FDA to Exempt Several Unclassified Medical Devices from Premarket Notification
New guidance identifies low-risk devices in eight medical specialties that will no longer require 510(k) submissions to reduce regulatory burdens.
New guidance identifies low-risk devices in eight medical specialties that will no longer require 510(k) submissions to reduce regulatory burdens.
Draeger expands its correction for Atlan models due to potential mechanical ventilation failure.
The new Powerseal Open Extended Jaw device is the fourth addition to the company's advanced bipolar surgical energy portfolio.
The system is designed to improve workflow efficiency and safety during minimally invasive left-heart procedures.
The Food and Drug Administration identifies the software update and nebulizer restrictions as the most serious type of recall.
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.